Centre for Addiction and Mental Health

The Centre for Addiction and Mental Health (CAMH) is a consortium of mental health clinics at several sites in Toronto, Ontario, Canada. Its name in French is Centre de toxicomanie et de santé mentale. (The acronym CAMH is most commonly pronounced "Cam-H".) Among the focuses of the organization are the assessment and treatment of schizophrenia, mood & anxiety disorders, and personality disorders. There is also a focus on addictions to alcohol, drugs, and problem gambling at the former ARF site. CAMH also has a Law and Mental Health Programme (forensic psychiatry and forensic psychology) and is a major research centre. CAMH is a teaching hospital with central facilities located in Toronto and 26 community locations throughout the province of Ontario. CAMH is fully affiliated with the University of Toronto and is a Pan American Health Organization and World Health Organization Collaborating Centre. In October 2008, CAMH was named one of "Canada's Top 100 Employers" by Mediacorp Canada Inc., and was featured in Maclean's newsmagazine. Later that month, CAMH was also named one of Greater Toronto's Top Employers, which was announced by the Toronto Star newspaper.

Website
http://www.camh.net/
Wikipedia
http://en.wikipedia.org/wiki/Centre_for_Addiction_and_Mental_Health

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Psychology & Psychiatry

Anti-psychotic medication linked to adverse change in brain structure

In a first-of-its-kind study using advanced brain imaging techniques, a commonly used anti-psychotic medication was associated with potentially adverse changes in brain structure. This study was the first in humans to evaluate ...

Psychology & Psychiatry

Study finds potential new treatment for preventing PTSD

Research led by the Centre for Addiction and Mental Health (CAMH) published in the Journal of Clinical Investigation points to a groundbreaking discovery about a new potential treatment and prevention for post-traumatic stress ...

Psychology & Psychiatry

Study reveals a new target for developing treatments for depression

A new CAMH study shows for the first time that people experiencing clinical depression have higher levels of a brain protein called MAO-B. The finding—published online today in JAMA Psychiatry - opens the door to a new ...

page 1 from 9